NCT04231591View on ClinicalTrials.gov

NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions

Congenital Heart DiseasePregnancy Complications

Interventions

DIAGNOSTIC_TEST

NT-proBNP

Collect serum NT-proBNP levels in singleton ACHD patients and a comparative normotensive control group at time of admission for delivery to characterize negative predictive values for intrapartum and postpartum cardiac events.

Trial Locations (1)

55905

Mayo Clinic, Rochester